High dosage valbenazine formulation and compositions, methods, and kits related thereto | Patent Number 11311532

US 11311532 B2
Application Number17074383
Publication NumberUS 20210030744 A1
Pendency1 year, 6 months, 9 days
Filled DateOct 19, 2020
Priority DateSep 21, 2017
Publication DateFeb 4, 2021
Expiration DateSep 20, 2037
Inventor/ApplicantsChristopher F. O'Brien
Christopher F. O`Brien
Richard Alexander Moore, Jr.
Richard Alexander Moore, JR.
Gregory A. McClelland
ExaminesTCHERKASSKAYA, OLGA V
Art Unit1615
Technology Center1600
Assignments
Neurocrine Biosciences
Current
Neurocrine Biosciences
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.